Tandlægeselskabet Colosseum Vejle ApS — Credit Rating and Financial Key Figures
CVR number: 40990909
Orla Lehmannsgade 1 A, 7100 Vejle
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Fiscal period length | 12 | 12 | 12 | 12 | 12 |
Net sales | |||||
Gross profit | 10 812.38 | 12 815.39 | 14 338.86 | 15 883.35 | 15 363.06 |
Employee benefit expenses | -9 971.47 | -10 523.97 | -12 481.06 | -13 563.46 | -13 664.89 |
Total depreciation | - 330.73 | - 634.03 | - 892.85 | -1 114.66 | -1 072.94 |
EBIT | 510.17 | 1 657.39 | 964.95 | 1 205.24 | 625.23 |
Other financial income | 6.53 | 0.60 | 14.57 | 21.53 | |
Other financial expenses | - 136.87 | - 146.50 | -95.16 | -61.10 | -94.23 |
Pre-tax profit | 379.84 | 1 511.49 | 869.79 | 1 158.70 | 552.53 |
Income taxes | - 333.00 | - 240.59 | - 412.00 | -32.10 | |
Net earnings | 379.84 | 1 178.49 | 629.20 | 746.70 | 520.43 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Intangible assets total | |||||
Buildings | 8.30 | 664.75 | 523.20 | 390.31 | |
Machinery and equipment | 2 793.14 | 2 462.32 | 2 611.69 | 2 229.32 | 1 336.32 |
Tangible assets total | 2 793.14 | 2 470.62 | 3 276.45 | 2 752.51 | 1 726.63 |
Investments total | 129.22 | 129.22 | 129.22 | 24.25 | |
Long term receivables total | |||||
Raw materials and consumables | 182.03 | 120.00 | 120.00 | 135.00 | |
Finished products/goods | 129.54 | ||||
Inventories total | 129.54 | 182.03 | 120.00 | 120.00 | 135.00 |
Current trade debtors | 459.60 | 398.92 | 462.31 | 314.18 | 346.94 |
Current owed by particip. interest comp. | 492.43 | ||||
Prepayments and accrued income | 100.62 | 149.11 | 167.14 | 179.06 | 165.01 |
Current other receivables | 2 379.44 | 431.15 | 2 571.53 | 1 281.66 | 797.45 |
Short term receivables total | 2 939.67 | 1 471.61 | 3 200.98 | 1 774.90 | 1 309.39 |
Cash and bank deposits | 1 456.97 | 1 681.79 | 403.83 | 96.03 | 118.67 |
Cash and cash equivalents | 1 456.97 | 1 681.79 | 403.83 | 96.03 | 118.67 |
Balance sheet total (assets) | 7 448.53 | 5 935.27 | 7 130.47 | 4 743.44 | 3 313.95 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Share capital | 40.00 | 40.00 | 40.00 | 40.00 | 40.00 |
Shares repurchased | 2 187.53 | 2 934.23 | 520.43 | ||
Other reserves | -2 187.53 | ||||
Retained earnings | 379.84 | - 629.20 | - 746.70 | - 520.43 | |
Profit of the financial year | 379.84 | 1 178.49 | 629.20 | 746.70 | 520.43 |
Shareholders equity total | 419.84 | 1 598.33 | 2 227.53 | 786.70 | 560.43 |
Provisions | 32.75 | ||||
Non-current owed to participating | 1 920.00 | ||||
Non-current other liabilities | 505.53 | 348.19 | |||
Non-current deferred tax liabilities | 356.30 | 372.08 | 383.61 | ||
Non-current liabilities total | 2 425.53 | 348.19 | 356.30 | 372.08 | 383.61 |
Advances received | 94.04 | 129.54 | 97.82 | 69.23 | 61.00 |
Current trade creditors | 245.65 | 593.87 | 459.94 | 873.04 | 766.40 |
Current owed to participating | 1 453.89 | 536.97 | |||
Short-term deferred tax liabilities | 349.55 | 247.19 | 231.36 | 190.00 | |
Other non-interest bearing current liabilities | 2 809.58 | 2 378.81 | 3 741.70 | 2 411.04 | 1 319.75 |
Current liabilities total | 4 603.16 | 3 988.75 | 4 546.65 | 3 584.66 | 2 337.16 |
Balance sheet total (liabilities) | 7 448.53 | 5 935.27 | 7 130.47 | 4 743.44 | 3 313.95 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions

... and more!
No registration needed.